SCHEMBL24938407

SCHEMBL24938407

O=C(O)CCCOC(=O)CNC(=O)OC1CCC[C@@H](C(OC(O)CCCOC(=O)CNC(=O)OC2CCCCC2)c2ccccc2)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MMP2 P08253 2/20 0.31
MMP9 P14780 2/20 0.31
ANPEP P15144 2/20 0.31
LTA4H P09960 1/20 0.31
LAP3 P28838 1/20 0.31
NPEPPS P55786 1/20 0.31
ERAP2 Q6P179 1/20 0.31
ERAP1 Q9NZ08 1/20 0.31
CHRM2 P08172 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
ADRA1A P35348 1/20 0.31
OPRM1 P35372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18686112 0.88 ALDH1A1 (0.35) KDM4EALDH1A1MEN1KMT2ACHRM2
SCHEMBL18686292 0.88 REN (0.35) KDM4EALDH1A1MEN1KMT2ACHRM2
SCHEMBL18686103 0.76 EPHX1 (0.49) ALDH1A1MEN1KMT2ALMNA
SCHEMBL21162720 0.74 EPHX1 (0.39) KDM4EALDH1A1MMP2MMP9ANPEP
SCHEMBL21169166 0.71 EPHX1 (0.40) KDM4EALDH1A1MMP2MMP9ANPEP
SCHEMBL18686104 0.71 ALDH1A1 (0.50) KDM4EALDH1A1MEN1KMT2AFAAH
SCHEMBL18686291 0.69 ALDH1A1 (0.49) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL24938373 0.65 EPHX1 (0.38) MEN1KMT2ALMNATSHR
SCHEMBL18686272 0.65 EPHX1 (0.37) MEN1KMT2ATSHR
SCHEMBL2866869 0.60 EPHX1 (0.65) ALDH1A1TSHRFAAHMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119539-A1 PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF XWPharma Ltd. (KY) 2023-01-18 EP disclosed